Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Alumis Inc.

Alumis to Participate in Upcoming September Investor Conferences
From Alumis Inc.
Via GlobeNewswire
Tickers ALMS
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
From Alumis Inc.
Via GlobeNewswire
Tickers ALMS
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
From Alumis Inc.
Via GlobeNewswire
Tickers ALMS
Alumis Announces Initiation of Patient Dosing in Phase 2 Clinical Trial of ESK-001 for the Treatment of Plaque Psoriasis
From Alumis Inc.
Via Business Wire
Alumis Appoints Jörn Drappa M.D., Ph.D., as Chief Medical Officer and Roman G. Rubio, M.D., as Senior Vice President, Clinical Development and Translational Medicine
From Alumis Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.